Bangkok--28 Aug--Dr.SOMCHAI
Dr.Somchai the first Thai cosmeceutical company, which makes the company enters the international biotechnology indust anti - cancer drug with the next plan to submit a drug registration and pull the biotechnology into the skincare products to create high quality products.
Dr. Ornin Raungwattanasuk, Managing Director of Dr.SOMCHAI Brand said “ after last year, we obtained the United States patent of small molecule for anti-cancer , we have still continuously researched and developed in biochemical engineering for producing the best results prototype drug anti-cancer which specific to estrogen receptor in breast and ovarian cancer. Moreover, we have also developed a methodology for loading drug into cells resulting drug loaded cells flow to the targeted tumor. In animal trials we found that drug reduced the size of tumor dramatically. We have a plan to submit a drug registration in the future.
Past three years, the company has paid attention to biotechnology and utilizing biotechnology to create a new dimension of treatment at a genetic level. Moreover, we have an affiliate, which do a genome editing research for drug recovery and we have a research and development part for producing plant-based food, which is booming in food market trend.
A successful development in advanced biotechnology achieved by our company, which do the synergy to push up our skincare products with high quality and efficacy in reasonable price.
In the future, we intend to use more utilizing of biotechnology into skincare products give rise “The Best Bio-Dermocosmetics skincares.
This is the next step of my company is intended to research and development for producing new drugs, give rise customers access essential drugs and high quality skincare products.